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Background: The arthropod-borne Mayaro virus (MAYV) causes ‘Mayaro fever’, a disease of medical significance,
primarily affecting individuals in permanent contact with forested areas in tropical South America. Recently, MAYV
has attracted attention due to its likely urbanization. Currently, there are no licensed drugs against most
mosquito-transmitted viruses. Here, we investigated the in vitro anti-MAYV activity of the flavonoids quercetin and
its derivatives from the Brazilian shrub Bauhinia longifolia (Bong.) Steud.
Methods: Flavonoids were purified by chromatographic fractionation from leaf extracts of B. longifolia and
chemically identified as quercetin and quercetin glycosides using spectroscopic techniques. Cytotoxicity of purified
flavonoids and of EtOAc- and n-BuOH-containing flavonoid mixtures was measured by the dye-uptake assay while
their antiviral activity was evaluated by a virus yield inhibition assay.
Results: The following flavonoids were purified from B. longifolia leaves: non-glycosylated quercetin and its
glycosides guaijaverin, quercitrin, isoquercitrin, and hyperin. EtOAc and n-BuOH fractions containing these flavonoids
demonstrated the highest antiviral activity of all tested substances, while quercetin had the highest antiviral activity
amongst purified flavonoids. Quercetin, EtOAc, or n-BuOH fractions inhibited MAYV production by more than 90%
at 25 μg/mL, displaying a stronger antiviral effect than the licensed antiviral ribavirin. A mixture of the isomers
isoquercitrin and hyperin had a modest antiviral effect (IC90 = 104.9), while guaijaverin and quercitrin did not show
significant antiviral activity.
Conclusions: B. longifolia is a good source of flavonoids with anti-Mayaro virus activity. This is the first report of the
activity of quercetin and its derivatives against an alphavirus.
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Brazil remains extensively covered by tropical forests
and other natural ecosystems, despite high deforestation
rates. A critical effect of deforestation is the introduction
of new viruses into urban areas, providing ideal condi-
tions for the development of several arboviruses [1]. In-
deed, more than 200 species of arboviruses have been
isolated in urban areas in Brazil, including approximately* Correspondence: davisf@micro.ufrj.br
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article, unless otherwise stated.40 species causing diseases in humans, including the Mayaro
fever [2], which is caused by the Mayaro virus (MAYV).
Mayaro virus (MAYV), a member of the Togaviridae
family (genus Alphavirus), was first isolated in Trinidad in
1954 [3]. MAYV is closely related to Chikungunya and
other alphaviruses, producing an acute, self-limited dengue-
like illness that is accompanied by long-lasting arthralgia
[4,5]. Since the initial description of MAYV, several small
outbreaks of Mayaro fever have been reported in rural
communities in northern Brazil and in eastern Bolivia
[6-8]. Moreover, MAYV antibodies have been detected
in human and animal populations in Bolivia, Brazil,
Colombia, Panama, Peru, Surinam, Trinidad and Tobago,tral Ltd. This is an Open Access article distributed under the terms of the
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creasing viral dissemination [9-15].
Antibodies against MAYV are often detected in certain
species of monkeys, which are likely to be the main nat-
ural reservoir of the virus [16], while the main vectors
are mosquitoes of the Haemagogus species, although Ae-
des species might also act as MAYV vectors. Thus, it is
possible that, under appropriate conditions, MAYV can
be transmitted in urban areas [1].
In Brazil, MAYV is endemic to the Amazon region, but
cases of the disease have been observed elsewhere. Mayaro
fever outbreaks occurred in central regions in Brazil,
namely Itarumã (Goiás state) and in Peixe (Tocantins
state) [17], in 1987 and 1991, respectively. Also, three
cases of Mayaro fever were reported in Mato Grosso state
[18]. Also, a report from 2010 describes a young French
tourist being diagnosed with MAYV after visiting the Bra-
zilian Amazon [19]. The importance of controlling MAYV
spread or seeking treatment for the virus infection extends
beyond the Amazon region. As an alphavirus, MAYV can
serve as a model for other important viruses such as
Chickungunya virus, an emerging virus that has been
spread in Europe recently [20-22].
Currently, about 40 antiviral drugs are available for clin-
ical use, mainly targeting HIV and a small number of
other viruses [23]. Nevertheless, research efforts to ex-
plore the potential of natural products as sources of novel
low toxicity and high selectivity antiviral substances have
increased lately [24]. These natural products, also called
plant-derived products, are very attractive when compared
to synthetic molecules. This is true mainly because of the
low cytotoxicity, the rapid degradation in the environ-
ment, and because of the complexity of the chemistry in
these products, that should limit resistance and increase
the applicability of use, such as vector control studies
[25,26]. Because there are many approaches for the use of
natural products, the modes of action or the active com-
ponents they contain and the metabolic pathways they
interact with must be studied. This can be accomplished
initially by in vitro studies such as the cell culture ap-
proach in this paper.
Shrubs from the Bauhinia (Fabaceae) genus are found
in tropical regions of Asia, Africa, and Central and South
America. In Brazil, these plants are known as ‘pata-de-
vaca’ (cow’s foot) because of their leaf shape [27]. Tea
made from B. longifolia and B. forficata leaves is con-
sumed in certain regions of Brazil [28] for its anti-diabetic
properties (according to Brazilian folk medicine). Flavo-
noids, mainly kaempferol and quercetin derivatives, are
commonly found in plants in the Bauhinia genus [29].
Flavonoids have known antiviral potential, and a number
of reports describe their different antiviral mechanisms,
including inhibition of infectivity and replication, depend-
ing on the target virus [30].In view of this interesting scenario, in the present study
we evaluated the antiviral activity of Bauhinia longifolia
(Bong.) Steud. against MAYV replication in Vero cells.
We also determined the selective antiviral activity of puri-
fied quercetin and quercetin glycoside derivatives, as well
as of leaf extracts rich in these flavonoids.Methods
Plants, cells and viruses
In this study, leaves from wild specimens of Bauhinia
longifolia (Bong.) Steud. collected in the municipality of
Luz, Minas Gerais state (Brazil) were used. Plant species
authentication was performed by comparison with herbar-
ium specimens from the Institute of Biological Sciences
(Federal University of Minas Gerais, Belo Horizonte,
Brazil), where a voucher specimen (BHCB 18778) was
deposited.
Vero cells (African green monkey kidney, ATCC CCL-81)
were grown at 37°C with 5% CO2, in Dulbecco’s modified
Eagle’s medium (DMEM) (Life Technologies, USA) sup-
plemented with 5% fetal bovine serum (Cultilab, BRA),
50 IU/mL of penicillin, and 50 μg/mL of streptomycin
(Sigma-Aldrich, USA). Mayaro viruses (ATCC VR-66,
lineage TR 4675) were propagated in Vero cells and viral
stocks in 10% glycerol were kept at −70°C. Virus titer was
determined by plaque assay (described under ‘Antiviral ac-
tivity assay’).Extraction, fractionation, and purification of quercetin
derivatives
Air-dried and powdered leaves (1.5 Kg) were extracted
with MeOH at room temperature for 7 days. Pooled
methanol extracts were filtered and concentrated under
reduced pressure to produce a crude extract (95 g),
which was diluted in MeOH-H2O to a ratio of 9:1, and
then extracted successively with n-hexane, CH2Cl2, EtOAc,
and n-BuOH.
EtOAc (7 g) and n-BuOH (6 g) fractions were chroma-
tographed separately on amberlite XAD-16 columns
(2 m × 8 cm i.d.) (Sigma-Aldrich). Aqueous methanol
solutions (from 0% to 100%, with 10% increments) were
used as the mobile phase, and 11 fractions were col-
lected for each extract (fractions A1–A11 and B1–B11,
for EtOAc and n-BuOH, respectively). After thin layer
chromatography (TLC) analysis, selected fractions were
pooled in three groups: F1, including fractions A6–A9
(4.5 g); F2, including fractions A10–A11 (0.9); and F3,
including fractions B6–B11 (1.9).
F1 and F3 were chromatographed separately on Sepha-
dex LH-20 columns (30 cm × 45 mm) (Sigma-Aldrich)
with MeOH-H2O (1:1) as the mobile phase. F1 chroma-
tography yielded fractions containing guaijaverin (1) and
quercitrin (3), F2 fractions contained aglycon quercetin
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isoquercitrin (4a) and hyperin (4b).
Reverse-phase HPLC-DAD and TLC analyses
HPLC-DAD (High Performance Liquid Chromatography
with Diode Array Detector) and TLC (Thin Layer Chro-
matography) were used to analyze the chemical compos-
ition of EtOAc and n-BuOH fractions described above.
The mobile phase of HPLC-DAD analysis consisted of
(A) 1% phosphoric acid in water or (B) 1% phosphoric
acid in methanol. Gradients used were: 0–15 min 50–
70% of B followed by 15–25 min 70–100% of B. The
flow rate was 1 mL/min and the injection volume 20 μL.
The UV–vis spectra were recorded from 254 to 400 nm,
with detection at 254 and 365 nm. TLC was performed
on silica gel Plates 60 F254 (Merck, 20 × 20 cm, 0.5 mm
thickness), using ethyl acetate-methanol–water-acetic
acid (8:1:0.5:0.5) as eluent. After elution, TLC plates
were observed under 254 nm UV light and then sprayed
with solutions of NP (2-aminoethyldiphenylborinate 1%
in methanol) and PEG-400 (polyethylene glycol 5% in
ethanol) (both by Sigma-Aldrich, USA) before examin-
ation under 365 nm UV light. The presence of sugars
was confirmed by acid hydrolysis of glycosides on TLC
plates, and the sugar composition was inferred by com-
parison with standards of each of the following sugars:
arabinose, xylose, galactose, glucose, and rhamnose
(Sigma-Aldrich, USA). Final compound identification
was performed by extensive 1D- (1H and 13C) and 2D-
(COSY, HMBC, HSQC) NMR experiments, ESI-MS,
UV spectral analysis, and by comparison with literature
values.
Cytotoxicity and antiviral activity assays
Cytotoxicity analysis of B. longifolia-derived flavonoids,
EtOAc and n-BuOH fractions, was performed using a
dye-uptake method modified from Borenfreund and
Puerner [31]. Briefly, confluent cultures of Vero cells in
96-well microplates were treated with culture media
containing different concentrations of the substances be-
ing tested. After 24 hours, the culture medium was re-
placed by a solution of 50 μg/mL neutral red and the
cells were incubated for 3 hours, at 37°C, 5% CO2. Cells
were then fixed with 20% formaldehyde and extracted
with 50% methanol and 1% acetic acid, before measure-
ment of absorbance at λ490 nm, using a spectrophotom-
eter, to detect neutral red incorporation by living cells.
Absorbance results were used to calculate, by regression
analysis, the concentrations of the tested substances cap-
able of reducing cell viability by 50% and 90% relative to
controls (CC50 and CC90, respectively).
Antiviral activity was evaluated using a virus yield in-
hibition assay. Briefly, confluent cell monolayers grown
in 24-well plates were infected with MAYV (multiplicityof infection = 0.1) for 1 hour, then rinsed with PBS and
treated for 24 hours (at 37°C and 5% CO2) with different
concentrations (0–100 μg/ml) of flavonoids or extracts
diluted in culture medium. After treatment, culture su-
pernatants were recovered and used for titration of
extracellular infectious virus particles. For virus titration,
confluent cell monolayers in 24-well plates were infected
with serial dilutions of recovered supernatants for 1 hour
at 37°C, 5% CO2. After inoculum removal, cells were
rinsed with PBS and the monolayer was incubated with
fresh medium with 2% carboxymethylcellulose (Sigma-
Aldrich, USA) for 48 hours at 37°C, 5% CO2. Finally,
cells were fixed with 20% formaldehyde and stained with
0.5% crystal violet in 20% ethanol, and viral plaques were
counted. Ribavirin (Sigma-Aldrich, USA) was used as
positive control for MAYV replication inhibition. For
each substance or extract, IC50 and IC90 values were cal-
culated and used to obtain a selectivity index (SI),
expressed as the ratio CC50/IC50, and to estimate relative
potency (RP) as the ratio between ribavirin (reference
substance) IC90 and the tested substance’s IC90. Results
were presented as mean inhibitory/cytotoxic concentra-
tion ± SD, and t-tests were used to evaluate the statistical
significance of treatments relative to controls. P-values < 0.05
were considered statistically significant.
Results
Flavonoids quercetin and quercetin derivatives are found
in extracts of B. longifolia leaves
HPLC-DAD analysis revealed that EtOAc and n-BuOH
fractions from the methanol extract of B. longifolia show
similar chemical profiles (Figure 1A), displaying varying
proportions of five major compounds having UV absorp-
tion typical of flavonoids (Figure 1B).
Using NMR, ESI-MS, and UV spectral analyses, the
compounds in profile peaks from Figure 1A were identified
as: guaijaverin (quercetin-3-O-α-arabinoside, peak 1) [32];
quercetin (peak 2) [33]; quercitrin (quercetin-3-O-α-rham-
noside, peak 3) [34]; isoquercitrin (quercetin-3-O-β-gluco-
side, peak 4a); and hyperin (quercetin-3-O-galactoside,
peak 4b) [35]. Figure 2 shows the chemical structure of
these compounds, and Table 1 shows their correspond-
ing HPLC-DAD and ESI-MS data.
The simplicity of the foliar flavonoid metabolism of B.
longifolia is revealed by the absence of kaempferol deriva-
tives (commonly found in the genus) and by the identifi-
cation of quercetin derivatives only. Furthermore, the
presence of quercetin 3-O-monoglycosides suggests the
effective action of glycosilation enzymes such as 3-O-
transferases [36].
Cytotoxicity and antiviral activity
Quercetin, EtOAc, and n-BuOH fractions inhibited
MAYV replication in Vero cells in a dose-dependent
Figure 1 HPLC-DAD analysis detects flavonoids in extracts from B. longifolia. (A) 365 nm diode array chromatogram of EtOAc fraction from
the leaves of B. longifolia. (B) UV spectra of quercetin derivatives present in the EtOAc fraction.
Figure 2 Chemical structures of flavonoids identified in B.
longifolia. (1) guaijaverin (quercetin-3-O-α-arabinoside);
(2) quercetin; (3) quercitrin (quercetin-3-O-α-rhamnoside);
(4a) isoquercitrin (quercetin-3-O-β-glucoside); and (4b) hyperin
(quercetin-3-O-β-galactoside).
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(Table 2 and Figure 3). In contrast, mixtures of the iso-
mers isoquercitrin (4a) and hyperin (4b) or the antiviral
ribavirin were much less potent inhibitors of MAYV rep-
lication, with IC90 values above 100 μg/mL (Table 2 and
Figure 3). The monoglycosides guaijaverin and quercitrin
did not show significant antiviral activity in the concen-
trations tested here (Table 2). EtOAc had the highestTable 1 HPLC-DAD and ESI-MS data for quercetin
derivatives from the leaves of B. longifolia
tR [M-H] λ max
Compound Name (min) (m/z) (nm)
1 Guaijaverin 12.7 433 255, 354
2 Quercetin 22.1 301 255, 368
3 Quercitrin 14.4 447 256, 352
4a Isoquercitrin 9.3 463 256, 356
4b Hyperin 10.2 463 255, 356
tR – retention time (in min).
[M-H]- – pseudo molecular ion observed on the ESI-MS spectra at the
negative mode.
λ max – maximum absorption bands in the UV spectra.
Table 2 Cytotoxicity and anti-MAYV activity of purified quercetin and its derivatives EtOAc and n-BuOH extracts,









μg/ml μg/ml μg/ml μg/ml
Guaijaverin 795 ± 54 53 ± 5 >100 >100 Nd nd
Quercetin 941 ± 123 43 ± 4 10 ± 0.7 19 ± 0.7 94 5
Quercitrin 411 ± 46 41 ± 4 >100 >100 Nd nd
Isoquercitrin + hyperin (1:1) 265 ± 19 135 ± 11 59 ± 0.2 105 ± 3 4 1
EtOAc 3116 ± 405 49 ± 5 5 ± 0.3 25 ± 3.5 623 4
n-BuOH 418 ± 47 64 ± 3 3 ± 0.2 5 ± 0.3 208 20
Ribavirin 523 ± 42 215 ± 6 62 ± 4 112 ± 8 8 nd
a –50% and 90% cytotoxic concentration.
b –50% and 90% inhibitory concentration of viral replication.
c – Selectivity Index = CC50/IC50.
d – Relative Potency = standard IC90 / substance IC90.
nd – Not determined.
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tion necessary for antiviral activity is much lower than
that causing toxicity to these cells. A high SI is desirable,
although much lower values warrant further investiga-
tion (see the value for ribavirin obtained under the con-
ditions of this study). The Relative Potency was also
calculated using ribavirin as a reference, and n-BuOH
was 20 times more powerful than ribavirin in these con-
ditions. EtOAc (4) and quercetin (5) were also more
powerful than ribavirin.
Discussion
In this study, the antiviral activity of quercetin and quer-



















Figure 3 Anti-MAYV activity of different substances from B. longifolia
extracts from B. longifolia was evaluated by treating MAYV-infected cells wi
plaque counting. The graph shows the results from three independent exp
untreated controls) ± SD.the arbovirus Mayaro was investigated. EtOAc and n-
BuOH fractions containing a mixture of five flavonoids,
including quercetin and its glycoside derivatives (guaija-
verin, quercitrin, isoquercitrin, and hyperin, in different
proportions) displayed stronger antiviral activities than
those observed for the purified compounds and for the
antiviral ribavirin, used as a positive control. Quercetin
and the mixture of isoquercitrin and hyperin in identical
proportions showed significant anti-MAYV activity while
guaijaverin and quercitrin did not.
Importantly, quercetin displayed better selectivity to-
wards MAYV and improved potency (SI = 94 and RP = 5)
when compared to the antiviral ribavirin (SI = 8), clinic-










. The anti-MAYV activity of purified flavonoids or EtOAc and n-BuOH
th 0–100 μg/ml of these substances for 24 h, and then staining for viral
eriments. Data are presented as mean% virus yield (compared to
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eral other RNA and DNA viruses such as influenza,
hepatitis B, poliomyelitis, measles, and smallpox [37].
Also, the antiviral activity of quercetin was considerably
stronger and more selective than that of glycosilated
quercetin derivatives, suggesting that glycosilation re-
duces the antiviral activity of quercetin against MAYV. In
contrast, Yarmolinsky et al. [38] reported increased anti-
herpes simplex virus-1 (HSV-1) activity for the com-
pounds rutin (quercetin-3-O-rutinoside), kaempferol-3-O-
rutinoside, and kaempferol-3-O-robinobioside compared
to that of the respective non-glycosylated compounds
(quercetin and kaempferol). The difference in the find-
ings may be explained by the fact that MAYV and HSV-
1 are viruses with very different replication strategies.
The mixture of isoquercitrin and hyperin had anti-
MAYV activity similar to that displayed by ribavirin, but
the Selectivity Index was lower (4). This was due to the
higher toxicity of the isoquercitrin/hyperin mixture if
compared to ribavirin. However, the Relative Potency for
ribavirin and the isoquercitrin/hyperin were similar, sug-
gesting possible synergism between these isomeric flavo-
noids. The absence of anti-MAYV activity for guaijaverin
and quercitrin in the concentrations tested here suggests
that 3-O-glycosilation with arabinose and rhamnose is
particularly detrimental to the antiviral activity against
MAYV. This is an interesting finding already under in-
vestigation by our group.
According to Gould and Lister [39], flavonoids pro-
tect the plant against infection by microorganisms.
Therefore, it is not surprising that these compounds
are effective in vitro against a wide array of viruses, in-
cluding HSP-1, parainfluenza-3, influenza, and dengue
virus type-2 (DENV-2) [40-43], even though the anti-
viral mechanism for quercetin has not yet been fully
elucidated. Zandi et al. [42] suggested that quercetin
might prevent DENV-2 replication by inhibiting viral
RNA polymerase, in a similar mechanism to that de-
scribed for silymarin, a flavonoid mixture effective against
the hepatitis C virus [44]. Inhibition of viral RNA metab-
olism, through binding to virus RNA, is also the most
likely mechanism of action of the flavonol kaempferol
against the Japanese encephalitis virus (JEV) [45].
Conclusions
Our results show that B. longifolia is a valuable source
of flavonoids with antiviral activity against the arbovirus
MAYV. Although quercetin and its 3-O-glycosides are
fairly common in plants, this is the first report of anti-
MAYV activity for these flavonoids. Our data are an im-
portant step in the evaluation of natural products as
sources of novel drugs to be used in combination therapy,
to circumvent drug resistance, or to replace currently used
antivirals with unwanted cytotoxic effects.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RMK and DF conceived and designed the study. AES collected plant material,
performed all phytochemical experiments and wrote the initial draft of the
manuscript. KAY and TSS performed cytotoxicity and viral yield inhibition
assays. MDFM and RC revised the data and carried out statistical analyses.
MRS provided invaluable discussions on the chemical data and antiviral
chemistry. All authors read and approved the final manuscript.
Acknowledgements
The authors would like to thank CAPES, CNPq, FAPERJ, and INBEB for
financial support. We thank Cléber Barreto for the NMR analysis and Ana
Claudia Amaral for ESI-MS analysis.
Author details
1Natural Product Research Institute, Center of Health Sciences, Federal
University of Rio de Janeiro, Rio de Janeiro, Brazil. 2Microbiology Institute,
Virology Department, Federal University of Rio de Janeiro, Rio de Janeiro,
Brazil. 3Chemistry Institute, Biochemistry Department, Federal University of
Rio de Janeiro, Rio de Janeiro, Brazil. 4National Institute of Science and
Technology for Structural Biology and Bioimaging, Rio de Janeiro, Brazil.
Received: 20 January 2014 Accepted: 12 March 2014
Published: 28 March 2014
References
1. Figueiredo LTM: Emergent arboviruses in Brazil. Rev Soc Bras Med Trop
2007, 40:224–229.
2. Rosa APAT, Vasconcelos PFC, Rosa JFST: An Overview Of Arbovirology In Brazil
And Neighbouring Countries. Belém: Instituto Evandro Chagas; 1998.
3. Anderson CR, Downs WG, Wattley GH, Ahin NW, Reese AA: Mayaro virus: a
new human disease agent. II. Isolation from blood of patients in
Trinidad. Am J Trop Med Hyg 1957, 6:1012–1016.
4. Pinheiro FP, Freitas RB, Rosa JFT, Gabbay YB, Mello WA, LeDuc JW: An
outbreak of Mayaro virus disease in Belterra, Brazil. I. Clinical and
virological findings. Am J Trop Med Hyg 1981, 30:674–681.
5. Tesh RB, Watts DM, Russell KL, Damodaran C, Calampa C, Cabezas C,
Ramirez G, Vasquez B, Hayes CG, Rossi CA, Powers AM, Hice CL, Chandler LJ,
Cropp BC, Karabatsos N, Roehrig JT, Gubler DJ: Mayaro virus disease: an
emerging mosquito-borne zoonosis in tropical South America. Clin Infect
Dis 1999, 28:67–73.
6. Causey OR, Maroja OM: Mayaro virus: a new human disease agent. III.
Investigation of an epidemic of acute febrile illness on the River Guana
in Pará, Brazil, and isolation of Mayaro virus as causative agent. Am J
Trop Med Hyg 1957, 6:1017–1023.
7. Schaeffer M, Gajdusek DC, Lema AB, Eichenwald H: Epidemic jungle fevers
among Okinawan colonists in the Bolivian rain forest. I. Epidemiology.
Am J Trop Med Hyg 1959, 8:372–396.
8. Leduc JW, Pinheiro FP, Rosa APAT: An outbreak of Mayaro virus disease in
Belterra, Brazil. II. Epidemiology. Am J Trop Med Hyg 1981, 30:683–688.
9. Groot H, Kerr JA, Sanmartin C, Vidales H: Antibodies to yellow fever and
other arthropod-borne viruses in human residents of San Vicente de
Chucuri, Santander, Colombia. Am J Trop Med Hyg 1959, 8:175–189.
10. Pinheiro FP, LeDuc JW: Mayaro Virus Disease. In The Arboviruses,
Epidemiology And Ecology. Edited by Monath T. Boca Raton: CRC Press;
1998:138–148.
11. Tavares-Neto J, Freitas-Carvalho J, Nunes MR, Rocha G, Rodrigues SG,
Damasceno E, Darub R, Viana S, Vasconcelos PFC: Serologic survey for
yellow fever and other arboviruses among inhabitants of Rio Branco,
Brazil, before and three months after receiving the yellow fever 17D
vaccine. Rev Soc Bras Med Trop 2004, 37:1–6.
12. Torres JR, Russell KL, Vasquez C, Barrera R, Tesh RB, Salas R, Watts DM:
Family cluster of Mayaro fever, Venezuela. Emerg Infect Dis 2004,
10:1304–1306.
13. Navarrete-Espinoza J, Gomez-Dantes H: Arbovirus causing hemorrhagic
fever at IMSS. Rev Med Inst Mex Seguro Soc 2006, 44:347–353.
14. Mourão MPG, Bastos MS, Figueiredo RP, Gimaque JBL, Galusso ES, Kramer VM,
Oliveira CMC, Naveca FG, Figueiredo LTM: Mayaro Fever in the city of
Manaus, Brazil, 2007–2008. Vector Borne and Zoonotic Dis 2012, 12:42–46.
dos Santos et al. Parasites & Vectors 2014, 7:130 Page 7 of 7
http://www.parasitesandvectors.com/content/7/1/13015. Neumayr A, Gabriel M, Fritz J, Gunther S, Hatz C, Schimidt-Chanasit J, Blum J:
Mayaro virus infection in traveler returning from Amazon Basin, Northern
Peru. Emerg Infect Dis 2012, 18:695–696.
16. Cortez LP, Burlandy FM, Rebello MA: Efeito da tunicamicina sobre a
replicação do vírus Mayaro em células de Aedes albopictus. Rev Ciênc Méd
Biol 2003, 1:5–11.
17. Vasconcelos PFC, Rosa APAT, Pinheiro FP, Shope RE, Rosa JFST, Rodrigues SG,
Dégallier N, da Rosa ES T: Arboviruses Pathogenic For Man In Brazil. In An
Overview Of Arbovirology In Brazil And Neighbouring Countries. Edited by Rosa
APAT, Vasconcelos PFC, Rosa JFST. Belém: Instituto Evandro Chagas;
1998:72–99.
18. Coimbra TLM, Santos CLS, Suzuki A, Petrella SMC, Bisordi I, Nagamori AH,
Marti AT, Santos RN, Fialho DM, Lavigne S, Buzzar MR, Rocco IM: Mayaro
virus: imported cases of human infection in São Paulo state, Brazil.
Rev Inst Med Trop Sao Paulo 2007, 4:221–224.
19. Receveur MC, Grandadam M, Pistone T, Malvy D: Infection with Mayaro
virus in a French traveller returning from the Amazon region, Brazil.
Euro Surveill 2010, 18:1–4.
20. Fischer D, Thomas SM, Suk JE, Sudre B, Hess A, Tjaden NB, Beierkuhnlein C,
Semenza JC: Climate change effects on Chikungunya transmission in
Europe: geospatial analysis of vector’s climatic suitability and virus’
temperature requirements. Int J Health Geogr 2013, 12:1–12.
21. Schaffner F, Bellini R, Petric D, Scholte EJ, Zeller H, Rakotoarivony LM:
Development of guidelines for the surveillance of invasive mosquitoes
in Europe. Paras Vectors 2013, 6:209–219.
22. Kampen H, Werner D: Out of the bush: the Asian bush mosquito Aedes
japonicus japonicus (Theobald, 1901) (Diptera, Culicidae) becomes
invasive. Paras Vectors 2014, 7:59–69.
23. Yasuhara-Bell J, Yuanan L: Marine compounds and their antiviral activities.
Antiviral Res 2010, 86:231–240.
24. Newman DJ, Cragg GM: Natural products as sources of new drugs over
the 30 years from 1981 to 2010. J Nat Prod 2012, 75:311–335.
25. George DR, Finn RD, Graham KM, Sparagano OAE: Present and future
potential of plant-derived products to control arthropods of veterinary
and medical significance. Parasit Vectors 2014, 7:1–12.
26. Politi FAS, Figueira GMF, Araújo AM, Sampieri BR, Mathias MIC, Szabó MPJ,
Bechara GH, Santos LC, Vilegas W, Pietro RCLR: Acaricidal activity of
ethanolic extract from aerial parts of Tagetes patula L. (Asteraceae)
against larvae and engorged adult females of Rhipicephalus sanguineus
(Latreille, 1806). Parasit Vectors 2012, 5:295–306.
27. Cechinel-Filho V: Chemical composition and biological potential of plants
from the genus Bauhinia. Phytother Res 2009, 23:1347–1354.
28. Almeida ER, Guedes MC, Albuquerque JFC, Xavier H: Hypoglycemic effect
of Bauhinia cheilandra in rats. Fitoterapia 2006, 77:276–278.
29. Pizzolatti MG, Cunha Junior A, Szpoganicz B, Sousa E, Braz-Filho R,
Schripsema J: Flavonóides glicosilados das folhas e flores de Bauhinia
forficata (Leguminosae). Quim Nova 2003, 26:466–469.
30. Nijveldt RJ, van Nood EV, van Hoorn DEC, Boelens PG, van Norren K,
van Leeuwen PAM: Flavonoids: a review of probable mechanisms of
action and potential applications. Am J Clin Nutr 2001, 74:418–425.
31. Borenfreund E, Puerner JA: Toxicity determined in vitro by morphological
alterations and neutral red absorption. Toxicol Lett 1985, 24:119–124.
32. Kalegari M, Miguel MD, Dias JFG, Lordello ALL, Lima CP, Miyazaki CMS,
Zanin SMW, Verdam MCS, Miguel OG: Phytochemical constituents and
preliminary toxicity evaluation of leaves from Rourea induta Planch.
(Connaraceae). Braz J Pharm Sci 2011, 3:635–642.
33. Fossen T, Andersen OM: Spectroscopic Techniques Applied To Flavonoids.
In Flavonoids: Chemistry, Biochemistry and Applications. Edited by Andersen
OM, Markham KR. Boca Raton: Taylor & Francis Group; 2006:37–142.
34. Piccinelli AL, Veneziano A, Passi S, Simone F, Rastrelli L: Flavonoids
glycosides from whole cottonseed by product. Food Chem 2007,
100:344–349.
35. Rodrigues ED, Silva DB, Oliveira DCR, Silva GVJ: DOSY NMR applied to
analysis of flavonoid glycosides from Bidens sulphurea. Magn Reson Chem
2009, 47:1095–1100.
36. Davies KM, Schwinn KE: Molecular Biology and Biotechnology of
Flavonoid Biosynthesis. In Flavonoids: Chemistry, Biochemistry and
Applications. Edited by Andersen OM, Markham KR. Boca Raton: Taylor &
Francis Group; 2006:168–169.37. Elia G, Belloli C, Cirone F, Lucente MS, Caruso M, Martella V, Decaro N,
Buonavoglia C, Ormas P: In vitro efficacy of ribavirin against canine
distemper virus. Antiviral Res 2008, 77:108–113.
38. Yarmolinsky L, Huleihel M, Zaccai M, Ben-Shabat S: Potent antiviral flavone
glycosides from Ficus benjamina leaves. Fitoterapia 2012, 83:362–367.
39. Gould KS, Lister C: Flavonoids Functions In Plants. In Flavonoids: Chemistry,
Biochemistry and Applications. Edited by Andersen OM, Markham KR. Boca
Raton: Taylor & Francis Group; 2006:416–417.
40. Orhan DD, Ozçelik B, Ozgen S, Ergun F: Antibacterial, antifungal, and
antiviral activities of some flavonoids. Microbiol Res 2010, 165:496–504.
41. Fan D, Zhou X, Zhao C, Chen H, Zhao Y, Gong X: Anti-inflammatory,
antiviral and quantitative study of quercetin-3-O-β-D-glucuronide in
Polygonum perfoliatum L. Fitoterapia 2011, 82:805–810.
42. Zandi K, Teoh B, Sam SS, Wong PF, Mustafa MR, Abubakar S: Antiviral
activity of four types of bioflavonoid against dengue virus type-2. Virol J
2011, 8:560.
43. Thapa M, Kim Y, Desper J, Chang KO, Hua DH: Synthesis and antiviral
activity of substituted quercetins. Bioorg Med Chem Lett 2012, 22:353–356.
44. Wagoner J, Negash A, Kane OJ, Martinez LE, Nahmias Y, Bourne N, Owen
DM, Grove J, Brimacombe C, McKeating JA, Pécheur EI, Graf TN, Oberlies
NH, Lohmann V, Cao F, Tavis JE, Polyak SJ: Multiple effects of silymarin on
the hepatitis C virus lifecycle. Hepatology 1912–1921, 2010:51.
45. Zhang T, Wu Z, Du J, Hu Y, Liu L, Yang F, Jin Q: Anti- Japanese-encephalitis-viral
effects of kaempferol and daidzin and their RNA-Binding characteristics.
PLoS One 2012, 7:e30259.
doi:10.1186/1756-3305-7-130
Cite this article as: dos Santos et al.: Quercetin and quercetin 3-O-
glycosides from Bauhinia longifolia (Bong.) Steud. show anti-Mayaro
virus activity. Parasites & Vectors 2014 7:130.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
